Workshop : “Pricing of Pharmaceutical Products”

2008-05-13

Workshop : “Pricing of Pharmaceutical Products”

The Event

The rise in costs of pharmaceutical products in general affects all sectors of the health care industry, including private insurers and patients. This workshop shall give an overview on the international pricing practices of pharmaceutical products for human use as well as the applications of Pharmacoeconomics. In addition, a thorough discussion on the proposed pricing policy by SFDA shall be presented.

Objectives

Overview on the regional and international regulatory agencies pricing policies.

Industrial perspective on pricing policies.

Application of pharmacoeconomics.

Current and proposed changes on the Saudi Pricing Guidelines.

Main Topics

Importance of pharmaceutical pricing & its Impact on the Market.

Pharmaceutical pricing strategies.

Pharmaceutical Pricing Policies in some countries: Jordan, Egypt and UAE.

Pharmaceutical Prices Information Service Provided by Austrian Health Institute (OEBIG).

Pharmaceutical pricing , Industry perspective.

European experience in pharmacoeconomics.

The role of pharmacoeconomics in pharmaceutical pricing in Australia.

SFDA pharmaceutical prices study.

Proposed pharmaceutical pricing guidelines by SFDA.

Saudi Food & Drug Authority pharmacoeconomics guidelines

Agenda

Day ONE
08: 00 – 09:00	Registration and refreshments
Opening Session	Opening Ceremony
0900-0905	Opening Ceremony with verses from the Holy Quran
0905-0910	Welcome speech and Opening Remarks Prof. Saleh A. Bawazir, Vice-President for drug affairs, SFDA
0910-0915	SFDA-president Speech Prof. Mohammed A. AlKanhal, President SFDA
Session ONE:	Pharmaceutical Pricing	Moderator: Prof. Mohammed A. AlKanhal
0915-0950	Importance of the Pharmaceutical Pricing & its Impact on the Market Dr. Andreas Seter, Senior Health Specialist-Pharmaceuticals, The World Bank
0950-1030	SFDA Pharmaceutical Prices Study (Preliminary Results) Dr. Mohammed AlSultan, King Saud University
1030-1045	Panel Discussion
1045-1115	Refreshment Break
Session TWO:	Pharmaceutical Pricing Policies – International Experience	Moderator: Mr. Mohammad AlHaidary
1115-1145	Global Pricing Policies World Health Organization (WHO)
1145-1215	Pharmaceutical Price Information Service Austrian Health Institute (OEBIG)
1215-1245	Pharmaceutical Pricing from Industrial Companies Perspective International Pharmaceutical Company
1245-1300	Panel Discussion
1300-1400	Lunch & Prayer Break
Session THREE:	Pharmacoeconomics	Moderator: Dr. Mohammad AlSultan
1400-1430	European Experience in Pharmacoeconomics TBA
1430-1500	The Role of Pharmacoeconomics in Pharmaceutical Pricing in Australia TBA
1500-1530	Proposed Pharmacoeconomic Guidelines for SFDA Dr. Senaa AlAqeel, King Saud University
1530-1550	Panel Discussion
1550	Close

Day TWO
0800-0830	Registration and Refreshments
Session FOUR:	Pharmaceutical Pricing Policies – Regional Experience	Moderator: Dr. Ali AlZawawi
0830-0900	Pharmaceutical Pricing Policy in Egypt Ministry of Health and Population, Egypt
0900-0930	Pharmaceutical Pricing Policy in Jordan Jordan Food & Drug Administration
0930-1000	Pharmaceutical Pricing Policy in United Arab Emirates Ministry of Health, UAE
1000-1015	Panel Discussion
10015-1045	Refreshment Break
Session FIVE:	Pharmaceutical Pricing Policies in Saudi Arabia	Moderator: Prof. Mohammed AlMeshal
1045-1115	Proposed Changes on the Current Pharmaceutical Pricing Guidelines Hajed Hashan, PhD, Head of Registration Department, SFDA
1115-1145	Panel Discussion
1145-1200	Closing Ceremony
1200	Lunch & Prayer Break

Who should attend?

Healthcare Executives

Pharmaceutical Services Directors

Economists

Pharmaceutical Industry

Healthcare Practitioners

Health In s ura n ce Professionals

Pharmacy Students

Law professionals

Who are the Speakers?

Speaker	Position
Dr. Andreas Seter	Senior Health Specialist-Pharmaceuticals, The World Bank
Dr. Mohammed AlSultan	Assistant professor, King Saud University
Dr. Sina'a Al-Ageel	Assistant Professor, King Saud University
Dr.Hajed Hashan	Head of Registration Department, SFDA
Dr. Ashraf Hassan Bayoumi	Consultant for center administration for pharmaceutical affairs, the Ministry of Health & Population, Egypt
Laila Ghazi Jarrar	Drug Directorate Director, JFDA
Claudia Aloisia	Senior Health Economist, Austrian Health Institute Vienna